FDA has revised a draft guidance, titled Chronic Hepatitis C Virus Infection: Developing Direct-Acting Antiviral Drugs for Treatment. [PDF 665 KB] The purpose of the guidance is to assist sponsors in the clinical development of direct-acting antiviral
Read More...
Read the complete post at https://blog.aids.gov/2016/05/fda-issues-revised-draft-guidance-on-developing-new-hep-c-treatments.html
Posted
May 06 2016, 06:00 AM
by
blog.aids.gov — HIV Policy & Programs. Research. New Media.